Shire Share Discussion Threads

[rodrod1] 28/4/2008 10:34

their clients probably sold on that advice friday :(

[hursheel] 28/4/2008 10:32

BROKERWATCH Shire downgraded to 'underperform' at Credit Suisse, 823p target
AFXU

[rodrod1] 28/4/2008 09:32

testing the historical low after the market viewed last friday's announcement negatively. imo
seems to have bounced a little back towards the £9 point. hopefullu more knowledgable posters may comment!

[aclark9201] 28/4/2008 09:00

Anyone know the reasons for this mornings fall?

[the_doctor] 25/4/2008 12:19

When enough of Vyvanse is taken out of the market cap, SHP will probably be taken over IMO.

Not currently sure when that point will be though....

[jimmy c] 25/4/2008 08:33

any stamp duty paid on these now they're foreign registered?

[zho] 18/3/2008 11:20

Shire takeover talk gallops on
March 18, 2008 10:35 AM

The takeover buzz surrounding pharmaceuticals group Shire refuses to die down. It is the top riser in the FTSE 100 index, up 65.5p to £10.64 on hopes of a bid from US rival Pfizer, or perhaps AstraZeneca.

Friday saw the start of this latest spate of speculation, with an unusually large number of Shire shares traded. This morning Swiss bank UBS has added fuel to the fire by saying Astra, up 9p to £17.57, could afford to pay £14.25 a share for Shire.

UBS said: "Our cost of capital (breakeven) M&A analysis suggests that AstraZeneca can pay up to 1425p, greater than a 40% premium, and achieve an economically
accretive acquisition. Assuming a deal completes on 1 January 2009, our earnings per share accretion / dilution analyses suggest that, in an all-cash deal with a 40%premium, AstraZeneca can achieve 2%-9% core earnings accretion in years 2009 to 2011.

"We estimate AstraZeneca could likely raise an incremental $17bn to acquire Shire
but note that credit agencies may have issue with certain loss scenarios on Seroquel
and Nexium. Because deal rationale suggest Shire would mostly be a financial
acquisition for AstraZeneca, a bid would to us confirm that many of AstraZeneca's
problems are in fact related to the long-term maintenance of margins."

[tonysss13] 14/3/2008 10:20

Subject: Stockwatch
Date: Fri 14th Mar 2008 9:51:40
Country: UK
Industry: Pharmaceuticals & Biotechnology
Company: Shire PLC, Pfizer Inc


STOCKWATCH Shire storms higher, traders note Pfizer bid talk

LONDON (Thomson Financial) - Shares in Shire stormed more than 7 pct higher in morning deals as traders noted vague talk that US giant Pfizer is casting an acquisitive eye over the UK healthcare group.
At 9.46 am, Shire shares led the FTSE 100 risers, up 67 pence, or 7.10 pct, at 1,010 pence.
"There's a rumour Pfizer are looking at Shire," said one London based trader.
Another said he had heard talk of a 1,300 pence per share bid.
[e-mail]
dlh/ajb

COPYRIGHT

Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.



www.afxpress.com

[aclark9201] 14/3/2008 09:48

What's happening here then? Why the big jump, anyone?

[markth] 15/2/2008 23:27

Nasty stammer there RFV.

I too am long again.

[rfv] 01/2/2008 15:34

I'm still there. But as what is happening - unless the usual oversold statement.

[rfv] 01/2/2008 15:34

I'm still there. But as what is happening - unless the usual oversold statement.

[the_doctor] 01/2/2008 14:51

Bah... literally picked the bottom perfectly, but recent losses caused by to lose my nerve and I took profits way too early on a little pullback :o(

[rfv] 01/2/2008 09:15

I'm in as of 906.

[jimmy c] 01/2/2008 08:28

I would not want to be short of Shire Pharma.

[the_doctor] 31/1/2008 17:22

I should have stuck with my instincts and not had stops as close.

[jimmy c] 31/1/2008 17:14

Don't be alarmed as i only trade the short side of things but........

Went long this afto. Got a good bit of info on these at dinner time. Nuff said. £11.

[the_doctor] 31/1/2008 10:37

Stops moved up and too close. I'm out for a small profit this time.

[the_doctor] 31/1/2008 09:31

I'm using close stops.... I'll catch the big move sometime!?

[rfv] 31/1/2008 09:24

Any bets for the time being are gambles. Good Luck doctor there ought to be a bounce - but from where? I'm still out by the way - I've invested in Shire since 1999 and this is the first time that I have not held any stock. Selling out at £11.60 seemed short sighted at the time but of course now I'm glad.

[the_doctor] 31/1/2008 09:17

... went long anyway. Still think its oversold and due a bounce

[the_doctor] 31/1/2008 09:13

Got stopped out below 900 yesterday. Turned out that was a good thing.

So how low can it go?
I'd buy here, but the markets are dragging it down and I'm unconvinced that they'll turn up again yet?

[the_doctor] 30/1/2008 15:59

"which is already considered to be at a premium to its peers"

Mid/spec Pharma, are you sure? Its 12-14x for Big Pharma

"No chance of being taken over at this level"
The acquirer would be able to see through the short term issues that you talk of. The New River acquisition is positive long term

[liquidkid] 30/1/2008 13:47

Thing is, it's coming down off a very high valuation, which even at 900p is still a high valuation
It's at something like 16x 2007 EBITDAE which is already considered to be at a premium to its peers. The debt coupled with the $2bn vyvanse acquisition write off is going to make the financials a mess for the FY earnings statement too. No chance of being taken over at this level.

[the_doctor] 30/1/2008 13:14

I think I sold out at the low of the day :o(
But had gone in big with a close stop. My concern was that others' stops below 900 would see it move swiftly lower.

I'll consider getting back in if the markets react favourably to the Fed decision...

Edit: bought back in